Anestezide xenon: Geçmiş ve günümüz

Xenon renksiz, kokusuz, tatsız ve tek atomlu bir gazdır. Sıvı havanın fraksiyone distilasyonundan elde edilir. Uzun zamandır anestezik olarak bilinmektedir. Xenon anestezisi bir çok deneysel klinik çalışmada değerlendirilmiş, emniyetli ve etkili özelliğinin yanı sıra ideal bir anesteziğin bir çok özelliğine sahip olduğu ortaya konmuştur. Anestezik etkisinin yanında, analjezik ve özellikle beyin ve kalpte önemli oranda organ koruyucu etkiler göstermektedir. Çevre dostudur ve ozona zarar verici etkisi yoktur, ancak maliyeti nedeniyle klinik pratikte sınırlı kullanılmaktadır.

Anahtar Kelimeler:

Anestezi, Xenon, Anestezikler

Xenon in anesthesia: Past and present

Xenon is a colorless, odorless, tasteless monatomic gas. It is manufactured by fractional distillation of liquid air. It has long been recognized that xenon is an anesthetic. Xenon anesthesia has been evaluated in many experimental clinical trials that have demonstrated its safe and effective profile and also has many of the properties of an ideal anesthetic. Besides these anesthetic ef- fects, xenon has been shown to exert analgesic, substantial organoprotective properties, especially in the brain and the heart. It is environmentally friendly and does not have ozone depleting properties. However the limited use xenon in clinical practice is related to high cost.

Keywords:

Anesthesia, Xenon, Anesthetics,

PDF

___

1. Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth 2003; 91:709-17.
2. Dingley J, Ivanova-Stoilova TM, Grundler S, Wall T. Xenon: recent developments. Anaesthesia 1999; 54:335-46.
3. Aziz TS. Xenon in anesthesia. Int Anesthesiol Clin. 2001; 39:1-14.
4. Marx T, Schmidt M, Schirmer U, Reinelt H. Xenon anaesthesia. J R Soc Med 2000; 93:513-7.
5. Özköse Z. Yeni inhalasyon ajanları ve Xenon. Anestezi Dergisi 2006;14:219-227.
6. Goto T, Nakata Y, Morita S. Will xenon be a stranger or a friend?: the cost, benefit, and future of xenon anesthesia. Anesthesiology 2003; 98:1-2.
7. Lawrence JH, Loomis WF, Tobias CA, Turpin FH. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol 1946; 105:197-204.
8. Cullen SC, Gross EG.The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951; 113:580-2.
9. Goto T. Is there a future for xenon anesthesia? Can J Anesth 2002; 49: 335-8.
10. Petersen-Felix S, Luginbuhl M, Schnider TW, Curatolo M, Arendt-Nielsen L, Zbinden AM. Comparison of the analgesic potency of xenon and nitrous oxide in humans evaluated by experimental pain. Br J Anaesth 1998; 81:742-7.
11.Tonner PH. Xenon: one small step for anaesthesia? Curr Opin Anaesthesiol 2006; 19: 382-4.
12. Nakata Y, Goto T, Morita S. Comparison of inhalation inductions with xenon and sevoflurane. Acta Anaesthesiol Scand 1997; 41:1157–61.
13. Goto T, Saito H, Shinkai M, Nakata Y, Ichinose F, Morita S. Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. Anesthesiology. 1997; 86:1273-8.
14. Dingley J, King R, Hughes L, et al. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia. 2001; 56:829-35.
15. Coburn M, Kunitz O, Baumert JH, et al. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia.Br J Anaesth. 2005; 94:198-202.
16. Bedi A, Murray JM, Dingley J, Stevenson MA, Fee JP.Use of xenon as a sedative for patients receiving critical care. Crit Care Med. 2003; 31:2470-7.
17. Coburn M, Baumert JH, Roertgen D, et al. Emergence and early cognitive function in the elderly after xenon or desflurane anaesthesia: a double- blinded randomized controlled trial. Br J Anaesth. 2007;98:756-62.
18. Goto T, Saito H, Nakata Y, Uezono S, Ichinose F, Morita S. Emergence times from xenon anaesthesia are independent of the duration of anaesthesia. Br J Anaesth 1997; 79:595- 9.
19. Sanders RD, Maze M. Xenon: from stranger to guardian. Curr Opin Anaesthesiol. 2005; 18:405-11.
20. Hecker K, Baumert JH, Horn N, Rossaint R. Xenon, a modern anaesthesia gas. Minerva Anestesiol. 2004; 70:255-60.
21. Ruzicka J, Benes J, Bolek L, Markvartova V. Biological effects of noble gases. Physiol Res. 2007; (suppl.1):39-44.
22. Nakata Y, Goto T, Ishiguro Y, et al. Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 2001; 94:611-4.
23. Sanders RD, Ma D, Maze M. Xenon: elemental anaesthesia in clinical practice. Br Med Bull 2005; 71:111-5.
24. Goto T, Hanne P, Ishiguro Y, Ichinose F, Niimi Y, Morita S.. Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl-midazolam anaesthesia. Anaesthesia. 2004; 59:1178-83.
25. Fujii Y. Respiratory effects of xenon. Int Anaesthesiol Clin 2001; 39: 95-103.
26. Wappler F, Rossaint R, Baumert J, et al. Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology 2007; 106: 463-71.
27. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organprotective actions of xenon. Anesthesiology. 2006; 105:187-97.
28. Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002; 96:1485–91.
29. Homi HM, Yokoo N, Ma D, et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99:876-81.
30. Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U.Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005; 102:929-36.
31. Benavides R, Maze M, Franks NP.Expansion of gas bubbles by nitrous oxide and xenon. Anesthesiology. 2006; 104:299-302.
32. Tenbrinck R, Hahn MR, Gultuna I, et al. The first clinical experiences with xenon. Int Anesthesiol Clin 2001; 39:29-42.